MYC and cancer: Results showed a dose-dependent efficacy of MP1 on inhibiting sphere counts/formation and MYC protein expression in both PDX cell lines (Fig. 1E, Supplementary Fig. S1C), suggesting anti-cancer efficacy of MP1 on MB spheres.